| Literature DB >> 34238263 |
Sanna Toppila-Salmi1,2, Riikka Lemmetyinen3,4, Sebastien Chanoine5,6,7, Jussi Karjalainen8,9, Juha Pekkanen10,11, Jean Bousquet12,13, Valérie Siroux5.
Abstract
BACKGROUND: The aim was to identify risk factors for severe adult-onset asthma.Entities:
Keywords: Acetylsalicylic acid; Allergy; Asthma; Epidemiology; Sinusitis
Year: 2021 PMID: 34238263 PMCID: PMC8268541 DOI: 10.1186/s12890-021-01578-4
Source DB: PubMed Journal: BMC Pulm Med ISSN: 1471-2466 Impact factor: 3.317
Fig. 1Flowchart of the study population. Asthmatic patients drawn from the Finnish Drug Reimbursement register were over 30 years old. A total of 248 asthmatic patients were included in the longitudinal, population-based Mini Finland Health Survey. A total of 1400 asthmatic patients had recently (within 2 years) been diagnosed with asthma. Asthma was defined as adult onset if the subject responded that the onset of asthma symptoms and/or the age of asthma diagnosis was age 16 years or later
Association between self-reported demographic factors and severe and non-severe asthma groups
| Non-severe asthma | Severe asthma | P | |
|---|---|---|---|
| Female sex, n (%) | 793 (63.4) | 45 (45.0) | |
| Age, years, mean(SD) | 54.0 (12.2) | 58.7 (11.6) | |
| BMI1, mean (SD) | 26.9 (4.7) | 27.1 (5.5) | .94 |
| Baccalaureate/secondary school, n (%) | 754 (61.8) | 71 (76.3) | |
| Professional training, n (%) | 296 (26.0) | 35 (40.7) | |
| Ever smokers, n (%) | 720 (57.6) | 74 (74.0) | |
| 1st child, n (%) | 363 (29.0) | 22 (22.0) | .14 |
| ≥ 2 siblings, n (%) | 927 (75.9) | 84 (89.4) | |
| Growing up in the countryside/on a farm, n (%) | 937 (75.9) | 77 (80.2) | .39 |
| Severe childhood infections2, n (%) | 217 (18.0) | 11 (11.7) | .13 |
| Parental smoking, n (%) | 648 (51.8) | 53 (53.0) | .84 |
| Parental asthma and/or allergy, n (%) | 437 (36.1) | 29 (29.9) | .23 |
| NERD, n (%) | 124 (9.9) | 19 (19.0) | |
| CRSwNP, n (%) | 145 (11.6) | 7 (7.0) | .19 |
| ≥ 1 other disease3, n (%) | 843 (67.4) | 86 (86.0) | |
| ≥ 1 other allergic disease (AR/AC/AD), n (%) | 844 (67.5) | 63 (63.0) | .38 |
Bold values denote statistical significance at the p < 0.05 level
NERD = patient-reported NSAID-exacerbated respiratory disease; CRSwNP = chronic rhinosinusitis with nasal polyps; AR = allergic rhinitis; AC = allergic rhinoconjunctivitis, AD = atopic dermatitis. P values by Chi square test (dichotomous) or t-test (continuous variables). P values less than 0.05 were considered significant. 1BMI data were missing from 6 (6.0%) severe asthmatic patients and 29 (2.3%) non-severe asthmatic patients. 2pneumonia before or during school age and/or hospitalization due to infection at ≤ 3 years of age. 3Hypertension (n = 298), coronary artery disease (n = 120), rheumatoid arthritis (n = 60), psychiatric disorder (n = 86), diabetes (n = 54), glaucoma (n = 49), back disease (n = 367), arthritis (n = 244), empyema (n = 106), other chronic disease(s) except chronic bronchitis/bronchiectasis (n = 449). Education level = baccalaureate/secondary versus primary school; professional training = completed professional college/university/courses/trade school versus no professional training. Severe asthma (Sev-Q) was defined as self-reported severe asthma and asthma symptoms causing much harm and regular impairment and ≥ 1 oral corticosteroid course/year or regular oral corticosteroids and/or waking up in the night due to asthma symptoms/wheezing ≥ a few times/month. Missing values were included and regarded as “no”
Association of risk factors with severe adult-onset asthma by using a question-based definition of severe asthma (Sev-Q)
| Model 1 | Model 2 | |||
|---|---|---|---|---|
| OR1 (95% CI) | p1 | OR2 (95% CI) | p2 | |
No Yes | 1 2.12 (1.41–3.20) | 1 1.96 (1.16–3.30) | ||
| 1.033 (1.02–1.05) | 1.002 (0.98–1.03) | .88 | ||
| 1.010 (0.97–1.06) | .66 | Not entered | ||
No Yes | 1 0.50 (0.31–0.82) | 1 0.88 (0.48–1.65) | .70 | |
No Yes | 1 0.51 (0.33–0.80) | 1 0.62 (0.36–1.05) | .074 | |
No Yes | 1 2.10 (1.32–3.32) | 1 1.98 (1.11–3.52) | ||
No Yes | 1 0.69 (0.42–1.12) | Not entered2 | ||
No Yes | 1 2.66 (1.37–5.20) | 1 2.51 (1.17–5.41) | ||
No Yes | 1 1.29 (0.77–2.17) | .34 | Not entered | |
No Yes | 1 0.60 (0.32–1.15) | 1 0.55 (0.26–1.14) | .11 | |
No Yes | 1 1.05 (0.70–1.58) | .82 | Not entered | |
No Yes | 1 0.76 (0.48–1.19) | .22 | Not entered | |
No Yes | 1 2.13 (1.25–3.63) | 1 3.29 (1.75–6.19) | ||
No Yes | 1 0.57 (0.26–1.26) | 1 0.54 (0.22–1.30) | .17 | |
No Yes | 1 2.97 (1.67–5.28) | 1 2.68 (1.35–5.31) | ||
No Yes | 1 0.82 (0.54–1.25) | .36 | Not entered |
Bold values denote statistical significance at the p < 0.05 level
Model 1 = univariate analysis. Model 2 = multivariable analysis by the eleven variables that were associated at the p < 0.2 level in Model 1. NERD = patient-reported NSAID-exacerbated respiratory disease; CRSwNP = chronic rhinosinusitis with nasal polyps; AR = allergic rhinitis; AC = allergic rhinoconjunctivitis, AD = atopic dermatitis. 1continuous variables. 2The variables “1st child” and “ ≥ 2 siblings” correlated (p < 0.01, r = − 0.42, by Pearson’s correlation test); hence, to avoid multicollinearity, only the statistically significant variable “ ≥ 2 siblings” was added into the multivariable model. 2pneumonia before or during school age and/or hospitalization due to infection at ≤ 3 years of age. 3Hypertension (n = 298), coronary artery disease (n = 120), rheumatoid arthritis (n = 60), psychiatric disorder (n = 86), diabetes (n = 54), glaucoma (n = 49), back disease (n = 367), arthritis (n = 244), empyema (n = 106), other chronic disease(s) except chronic bronchitis/bronchiectasis (n = 449). Education level = baccalaureate/secondary versus primary school; professional training = completed professional college/university/courses/trade school versus no professional training. OR = odds ratio. CI = confidence interval. Severe asthma (Sev-Q) was defined as self-reported severe asthma and asthma symptoms causing much harm and regular impairment and ≥ 1 oral corticosteroid course/year or regular oral corticosteroids and/or waking up in the night due to asthma symptoms/wheezing ≥ a few times/month
Fig. 2Forest plot summarizing the associations between risk factors and severe adult-onset asthma by using a question-based definition of severe asthma (Sev-Q). Adjusted ORs and 95% CIs of severe adult-onset asthma are presented for sex, smoking status, the number of siblings, the presence of patient-reported NSAID-exacerbated respiratory disease (NERD), and other chronic diseases. Models were adjusted for all these risk factors and age, education, training, severe childhood infection(s)1 and the presence of chronic rhinosinusitis with nasal polyps. In this multivariable model, the number of severe asthmatic patients was 79, and the number of non-severe asthmatic patients was 1094. 1pneumonia before or during school age and/or hospitalization due to infection at ≤ 3 years of age. Education level = baccalaureate/secondary versus primary school; professional training = completed professional college/university/courses/completed trade school versus no. OR = odds ratio. CI = confidence interval. Severe asthma (Sev-Q) was defined as self-reported severe asthma and asthma symptoms causing much harm and regular impairment and ≥ 1 oral corticosteroid course/year or regular oral corticosteroids and/or waking up in the night due to asthma symptoms/wheezing ≥ a few times/month
Association of the sum of the risk factors (categorized as 0–1, 2–3, and 4–5 risk factors) with severe adult-onset asthma by using a question-based definition of severe asthma (Sev-Q)
| N1 total (n with severe asthma) | OR1 (95% CI) | p1 | N2 total (n with severe asthma) | OR2 (95% CI) | p2 | |
|---|---|---|---|---|---|---|
| 0–1 | 215 (3) | 1 | 215 (3) | 1 | ||
| 2–3 | 831 (47) | 4.24 (1.31–13.75) | 829 (45) | 4.06 (1.25–13.18) | ||
| 4–5 | 269 (44) | 13.82 (4.23–45.18) | 262 (37) | 11.62 (3.53–38.25) |
Bold values denote statistical significance at the p < 0.05 level
Risk factors were male sex, ≥ 2 siblings, ever smoking, NERD, and ≥ 1 other disease. When counting the total sum of the five risk factors, 27 (2.0%), 188 (13.9%), 433 (32.1%), 398 (29.5%), 260 (19.3%) and 9 (0.7%) had 0, 1, 2, 3, 4, and 5 risk factors, respectively. The risk for severe asthma (Sev-Q) significantly and gradually increased with the sum of the five risk factors (OR (95% CI) = 2.30 [1.81–2.93] for each additional unit, p < 0.001). NERD = patient-reported NSAID-exacerbated respiratory disease. OR = odds ratio. CI = confidence interval. Severe asthma (Sev-Q) was defined as self-reported severe asthma and asthma symptoms causing much harm and regular impairment and ≥ 1 oral corticosteroid course/year or regular oral corticosteroids and/or waking up in the night due to asthma symptoms/wheezing ≥ a few times/month. 1Complete patients in whom the variable data were available. 2More stringent definition of severe asthma by including only those subjects with regular use of inhaled corticosteroid (Sev-Q + ICS)
Association of risk factors with severe adult-onset asthma by using a medication-based definition of severe asthma (Sev-OCS). Multivariate model
| Model 1 | Model 2 | |||
|---|---|---|---|---|
| OR1 (95% CI) | p1 | OR2 (95% CI) | p2 | |
No Yes | 1 1.20 (0.90–1.61) | 1 1.03 (0.73–1.46) | .87 | |
| 1.008 (1.00–1.02) | 1.012 (1.00–1.03) | .092 | ||
| 1.03 (1.00–1.06) | 1.31 (0.92–1.87) | .13 | ||
No Yes | 1 0.86 (0.63–1.17) | .33 | Not entered | |
No Yes | 1 0.81 (0.58–1.12) | .20 | Not entered | |
No Yes | 1 1.70 (1.25–2.31) | 1 1.69 (1.19–2.40) | ||
No Yes | 1 1.37 (1.01–1.86) | 1 1.34 (0.96–1.86) | .088 | |
No Yes | 1 0.92 (0.65–1.29) | .62 | Not entered | |
No Yes | 1 0.72 (0.52–0.99) | 1 0.69 (0.48–0.99) | ||
No Yes | 1 1.28 (0.89–1.84) | 1 1.03 (0.69–1.54) | .88 | |
No Yes | 1 1.23 (0.92–1.64) | 1 1.24 (0.90–1.69) | .19 | |
No Yes | 1 1.02 (0.75–1.37) | .92 | Not entered | |
No Yes | 1 1.37 (0.89–2.11) | 1 1.68 (1.06–2.69) | ||
No Yes | 1 0.98 (0.62–1.54) | .92 | Not entered | |
No Yes | 1 1.73 (1.24–2.43) | 1 1.49 (1.03–2.18) | ||
No Yes | 1 1.14 (0.83–1.55) | .42 | Not entered |
Bold values denote statistical significance at the p < 0.05 level
Model 1 = Univariate analysis. Model 2 = Multivariable analysis by the twelve variables that were associated at the p < 0.2 level in Model 1). In addition, we wanted to force age (p = 0.20) and sex (p = 0.021) in model 2 to obtain a more comparable model to the first model. Hence, a total of 10 variables were entered in a multivariable model. NERD = patient-reported NSAID-exacerbated respiratory disease; CRSwNP = chronic rhinosinusitis with nasal polyps; AR = allergic rhinitis; AC = allergic rhinoconjunctivitis, AD = atopic dermatitis. 1continuous variables. 2pneumonia before or during school age and/or hospitalization due to infection at ≤ 3 years of age. 3Hypertension (n = 298), coronary artery disease (n = 120), rheumatoid arthritis (n = 60), psychiatric disorder (n = 86), diabetes (n = 54), glaucoma (n = 49), back disease (n = 367), arthritis (n = 244), empyema (n = 106), other chronic disease(s) except chronic bronchitis/bronchiectasis (n = 449). Education level = baccalaureate/secondary versus primary school; professional training = completed professional college/university/courses/trade school versus no professional training. OR = odds ratio. CI = confidence interval. Severe asthma (Sev-OCS) was defined as those who reported regular use of oral corticosteroid in e and/or ≥ 2 corticosteroid courses/year due to asthma